Advertisement

Digestive Diseases and Sciences

, Volume 47, Issue 6, pp 1266–1278 | Cite as

Dietary Iron Supplementation Enhances DSS-Induced Colitis and Associated Colorectal Carcinoma Development in Mice

  • Darren N. Seril
  • Jie Liao
  • Kwok-Lam K. Ho
  • Asim Warsi
  • Chung S. Yang
  • Guang-Yu Yang
Article

Abstract

Chronic ulcerative colitis (UC) patients frequently require iron supplementation to remedy anemia due to blood loss. However, the effect of iron supplementation on UC-associated carcinogenesis is unknown. In this study, the effect of an iron-enriched diet on dextran sulfate sodium-induced acute and chronic colitis in mice was assessed. In a short-term study, mice administered 1% DSS in the drinking fluid and an AIN76A diet containing increasing levels of iron exhibited dose-dependent increases in the severity of acute UC as compared to mice fed a control diet. A marked increase in iron deposition on the epithelial surface of the colon and in the inflamed areas and immunostaining for iNOS and nitrotyrosine were observed in the animals supplemented with diets containing different levels of iron. In a long-term carcinogenesis experiment, a twofold iron-enriched diet significantly increased colorectal tumor incidence (14/16, 88%) as compared with animals fed the control diet (3/16, 19%; P < 0.001). The present findings have implications for the management of human UC and suggest that dietary iron can enhance UC and its associated carcinogenesis by augmenting oxidative and nitrosative stress.

ulcerative colitis iron supplementation inflammation oxidative damage carcinogenesis 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. 1.
    Fiocchi C: Inflammatory bowel discase: Etiology and pathogenesis. Gastroenterology 115:182–205, 1998PubMedGoogle Scholar
  2. 2.
    Collins RH Jr, Feldman M, Fordtran JS: Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review. N Engl J Med 316:1654–1658, 1987PubMedGoogle Scholar
  3. 3.
    Ekbom A, Helmick C, Zack M, Adami H-O: Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 323:1228–1233, 1990PubMedGoogle Scholar
  4. 4.
    Prior P, Gyde SN, Macartney JC, Thompson H, Waterhouse JAH, Allan RN: Cancer morbidity in ulcerative colitis. Gut 23:490–497, 1982PubMedGoogle Scholar
  5. 5.
    Meeting Report: Molecular mechanism for inflammationpromoted pathogenesis of cancer-the sixteenth international symposium of the Sapporo cancer seminar. Cancer Res 57:3620–3623, 1997Google Scholar
  6. 6.
    Barrison IG, Roberts PD, Kane SP: Oral or parenteral iron treatment in chronic ulcerative colitis? Br Med J (Clin Res Ed) 282:514, 1981Google Scholar
  7. 7.
    Sheth S, Brittenham GM: Genetic disorders affecting proteins of iron metabolism: Clinical implications. Annu Rev Med 51:443–464, 2000PubMedGoogle Scholar
  8. 8.
    Blake D, Bacon PA: The importance of iron in rheumatoid arthritis. Lancet 1:623, 1982Google Scholar
  9. 9.
    Reifen R, Matas Z, Zeidel L, Berkovitch Z, Bujanover Y: Iron supplementation may aggravate inflammatory status of colitis in a rat model. Dig Dis Sci 45:394–397, 2000PubMedGoogle Scholar
  10. 10.
    Meneghini, R: Iron homeostasis, oxidative stress, and DNA damage. Free Radic Biol Med 23:783–792, 1997PubMedGoogle Scholar
  11. 11.
    Babbs CF: Oxygen radicals in ulcerative colitis. Free Radic Biol Med 13:169–181, 1992PubMedGoogle Scholar
  12. 12.
    Stevens RG, Graubard BL, Micozzi MS, Neriishi K, Blumberg BS: Moderate elevation of body iron level and increased risk of cancer occurrence and death. Int J Cancer 56:364–369, 1994PubMedGoogle Scholar
  13. 13.
    Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R: A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98:694–702, 1990PubMedGoogle Scholar
  14. 14.
    Mahler M, Bristol IJ, Leiter EH, Workman AE, Birkenmeier EH, Elson CO, Sundberg JP: Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. Am J Physiol 274:G544–G551, 1998PubMedGoogle Scholar
  15. 15.
    Cooper HS, Murthy S, Kido K, Yoshitake H, Flanigan A: Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: a study of histopathology, ?-catenin, and p53 expression and the role of inflammation. Carcinogenesis 21:757–768, 2000PubMedGoogle Scholar
  16. 16.
    Tamaru T, Kobayashi H, Kishimoto S, Kajiyama G, Shimamoto, F, Brown WR: Histochemical study of colonic cancer in experimental colitis of rats. Dig Dis Sci 38:529–537, 1993PubMedGoogle Scholar
  17. 17.
    Yamada M, Ohkusa T, Okayasu I: Occurrence of dysplasia and adenocarcinoma after experimental chronic ulcerative colitis in hamsters induced by dextran sulphate sodium. Gut 33:1521–1527, 1992PubMedGoogle Scholar
  18. 18.
    Riddell RH, Goldman H, Ransohoff DF, Appelman HD, Fenoglio CM, Haggitt RC, Ahren C, Correa P, Hamilton SR, Morson BC, Sommers SC, Yardley JH: Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications. Hum Pathol 14:931–968, 1983PubMedGoogle Scholar
  19. 19.
    Goldstein SR, Yang G-Y, Chen X, Curtis SK, Yang CS: Studies of iron deposits, inducible nitric oxide synthase and nitrotyrosine in a rat model for esophageal adenocarcinoma. Carcinogenesis 19:1445–1449, 1998PubMedGoogle Scholar
  20. 20.
    Yang G-Y, Wang ZY, Kim S, Liao J, Seril DN, Chen XX, Smith TJ, Yang CS: Characterization of early pulmonary hyperproliferation and tumor progression and their inhibition by black tea in a 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanoneinduced lung tumorigenesis model with A/J mice. Cancer Res 57:889–1894, 1997Google Scholar
  21. 21.
    Babbs CF: Hypothesis paper: Free radicals and the etiology of colon cancer. Free Radic Biol Med 8:191–200, 1990PubMedGoogle Scholar
  22. 22.
    Konijn A: Iron metabolism in inflammation. Bailliere's Clin Haematol 7:829–849, 1994Google Scholar
  23. 23.
    Morris CJ, Earl JR, Trenam CW, Blake DR: Reactive oxygen species and iron-a dangerous partnership in inflammation. Int J Biochem Cell Biol 27:109–122, 1995PubMedGoogle Scholar
  24. 24.
    Herbert V, Shaw S, Jayatilleke E, Stopler-Kasdan, T: Most free-radical injury is iron-related: it is promoted by iron, hemin, holoferritin and vitamin C, and inhibited by desferroxamine and apoferritin. Stem Cells 12:289–303, 1994PubMedGoogle Scholar
  25. 25.
    Wink DA, Vodovotz Y, Laval J, Laval F, Dewhirst MW, Mitchell JB: The multifaceted roles of nitric oxide in cancer. Carcinogenesis 19:711–721, 1998PubMedGoogle Scholar
  26. 26.
    Reynolds PD, Middleton SJ, Hansford GM, Hunter JO: Nitric oxide in ulcerative colitis. Lancet 345:448–449, 1995Google Scholar
  27. 27.
    Jacob RA, Burri BJ: Oxidative damage and defense. Am J Clin Nutr 63:985S–990S, 1996PubMedGoogle Scholar
  28. 28.
    Peskin AV: Interaction of reactive oxygen species with DNA. A review. Biochemistry 62:1341–1347, 1997PubMedGoogle Scholar
  29. 29.
    Poulsen HE, Prieme H, Loft S: Role of oxidative DNA damage in cancer initiation and promotion. Eur J Cancer Prev 7:9–16, 1998PubMedGoogle Scholar
  30. 30.
    Schmidt C, Baumeister B, Kipnowski J, Schiermeyer-Dunkhase B, Vetter H: Alteration of prostaglandin E2 and leukotriene B4 synthesis in chronic inflammatory bowel disease. Hepato-Gastroenterol 43:1508–1512, 1996Google Scholar
  31. 31.
    Reddy BS, Rao CV, Seibert K: Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis. Cancer Res 56:4566–4569, 1996PubMedGoogle Scholar
  32. 32.
    Ablin J, Shalev O, Okon E, Karmeli F, Rachmilewitz D: Deferiprone, an oral iron chelator, ameliorates experimental colitis and gastric ulceration in rats. Inflamm Bowel Dis 5:253–261, 1999PubMedGoogle Scholar
  33. 33.
    Heimann TM, Oh AC, Martinelli G, Szporn A, Luppescu N, Lembo CA, Kurtz RJ, Fasy TM, Greenstein AJ: Colorectal carcinoma associated with ulcerative colitis: A study of prognostic indicators. Am J Surg 164:3–17, 1992Google Scholar
  34. 34.
    Sugita A, Greenstein AJ, Ribeiro MB, Sachar DB, Bodian C, Nannan Panday AK, Szporn A, Pozner J, Heimann T, Palmer M, Aufses AH Jr: Survival with colorectal cancer in ulcerative colitis. A study of 102 cases. Ann Surg 218:189–195, 1993PubMedGoogle Scholar
  35. 35.
    Goldman H: Significance and detection of dysplasia in chronic colitis. Cancer 78:2307–2312, 1996PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 2002

Authors and Affiliations

  • Darren N. Seril
    • 1
  • Jie Liao
    • 1
  • Kwok-Lam K. Ho
    • 1
  • Asim Warsi
    • 1
  • Chung S. Yang
    • 1
  • Guang-Yu Yang
    • 1
  1. 1.Laboratory for Cancer Research, Department of Chemical Biology, College of Pharmacy, Rutgers, The StateUniversity of New JerseyPiscatawayUSA

Personalised recommendations